![CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease | Scientific Reports CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-20324-2/MediaObjects/41598_2022_20324_Fig1_HTML.png)
CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease | Scientific Reports
Effect of denosumab compared to risedronate on bone strength in patients initiating or continuing glucocorticoid treatment
![Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease | Nature Communications Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-19473-7/MediaObjects/41467_2020_19473_Fig1_HTML.png)
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease | Nature Communications
![Boala Lupus. Tot ce trebuie sa stii despre lupusul eritematos sistemic | Bioclinica, Anticorpi anti-nucleari pentru durerile articulare Boala Lupus. Tot ce trebuie sa stii despre lupusul eritematos sistemic | Bioclinica, Anticorpi anti-nucleari pentru durerile articulare](http://avagardens.ro/images/a6292c0da238d039ed7533a44675ae46.jpg)